KA - Kineta - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

7.816M

Cash

1.773M

Avg Qtr Burn

-3.82M

Short % of Float

2.53%

Insider Ownership

34.91%

Institutional Own.

12.53%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
YTX-7739 Details Parkinson's disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KVA12123 Details Solid tumor/s, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.